188 related articles for article (PubMed ID: 12189724)
1. Aseptic processing of protein pharmaceuticals.
Townsend M
Pharm Biotechnol; 2002; 14():129-89. PubMed ID: 12189724
[No Abstract] [Full Text] [Related]
2. Are pharmaceutics really going supercritical?
Pasquali I; Bettini R
Int J Pharm; 2008 Dec; 364(2):176-87. PubMed ID: 18597957
[TBL] [Abstract][Full Text] [Related]
3. Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals.
Volkin DB; Sanyal G; Burke CJ; Middaugh CR
Pharm Biotechnol; 2002; 14():1-46. PubMed ID: 12189723
[No Abstract] [Full Text] [Related]
4. March of the synthesis machines.
Sanderson K
Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
[No Abstract] [Full Text] [Related]
5. Overview of drug product development.
Narayan P
Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
[TBL] [Abstract][Full Text] [Related]
6. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
[TBL] [Abstract][Full Text] [Related]
7. "Innovative processes for bio-pharmaceuticals and poorly water-soluble API".
Müller-Goymann C; Kwade A
Eur J Pharm Biopharm; 2018 May; 126():1. PubMed ID: 29474867
[No Abstract] [Full Text] [Related]
8. Laser irradiation to produce amorphous pharmaceuticals.
Titapiwatanakun V; Tankul J; Basit AW; Gaisford S
Int J Pharm; 2016 Nov; 514(1):282-289. PubMed ID: 27863673
[TBL] [Abstract][Full Text] [Related]
9. Critical considerations for the qualitative and quantitative determination of process-induced disorder in crystalline solids.
Newman A; Zografi G
J Pharm Sci; 2014 Sep; 103(9):2595-2604. PubMed ID: 24623166
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric synthesis of active pharmaceutical ingredients.
Farina V; Reeves JT; Senanayake CH; Song JJ
Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298
[No Abstract] [Full Text] [Related]
11. Preface: Additive manufacturing in pharmaceutical product design.
Rantanen J; Fatouros DG
Adv Drug Deliv Rev; 2021 Nov; 178():113991. PubMed ID: 34582829
[No Abstract] [Full Text] [Related]
12. Ozonolysis applications in drug synthesis.
Van Ornum SG; Champeau RM; Pariza R
Chem Rev; 2006 Jul; 106(7):2990-3001. PubMed ID: 16836306
[No Abstract] [Full Text] [Related]
13. Greener pharmaceuticals.
Clark JH; Breeden SW; Summerton L
Future Med Chem; 2009 Jun; 1(3):409-13. PubMed ID: 21426120
[No Abstract] [Full Text] [Related]
14. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions.
Gordon EM; Barrett RW; Dower WJ; Fodor SP; Gallop MA
J Med Chem; 1994 May; 37(10):1385-401. PubMed ID: 8182695
[No Abstract] [Full Text] [Related]
15. Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route.
Butters M; Catterick D; Craig A; Curzons A; Dale D; Gillmore A; Green SP; Marziano I; Sherlock JP; White W
Chem Rev; 2006 Jul; 106(7):3002-27. PubMed ID: 16836307
[No Abstract] [Full Text] [Related]
16. Expanding the scope of crystal form evaluation in pharmaceutical science.
Peterson ML; Hickey MB; Zaworotko MJ; Almarsson O
J Pharm Pharm Sci; 2006; 9(3):317-26. PubMed ID: 17207415
[TBL] [Abstract][Full Text] [Related]
17. Drug industry looks to the lab instead of rainforest and reef.
Service RF
Science; 1999 Jul; 285(5425):186. PubMed ID: 10428712
[No Abstract] [Full Text] [Related]
18. Effect of incomplete removal of the tert-butoxycarbonyl protecting group during synthesis of a pharmaceutical drug substance on the residual solvent analysis.
Beilin E; Baker LJ; Aikins J; Baryla NE
J Pharm Biomed Anal; 2010 Jun; 52(2):316-9. PubMed ID: 20116957
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceuticals and related drugs.
Gilpin RK; Gilpin CS
Anal Chem; 2007 Jun; 79(12):4275-93. PubMed ID: 17511425
[No Abstract] [Full Text] [Related]
20. New opportunities for biocatalysis: making pharmaceutical processes greener.
Woodley JM
Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
